Skip to main content

Long-term Safety Profile of Bimekizumab in axSpA and PsA

Dr. Philip Mease discusses abstract 2367, presented at the 2024 ACR Convergence meeting in Washington, DC.

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×